Last reviewed · How we verify
NCT05061602: DMumecPRO
Biomechanical and Viscoelastic Properties of Plantar Fascia in Diabetes Mellitus
trial testing Evaluation of biomechanics and viscoelastic properties of plantar fascia in Diabetes Mellitus in 50 participants. Completed in 10 July 2022.
30 May 2022
Quick facts
| Lead sponsor | Tülay Çevik Saldıran |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 50 |
| Start date | 20 September 2021 |
| Primary completion | 30 May 2022 |
| Estimated completion | 10 July 2022 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Evaluation of biomechanics and viscoelastic properties of plantar fascia
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
Sponsor
Tülay Çevik Saldıran
Who can join
18 and older, any sex, with Diabetes Mellitus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
In this study, an attempt has been made to analyze the changes in soft tissue biomechanical properties of plantar surface in diabetes. The second aim of this study was to explore the relationships between fear of falling, physical performance, and plantar stiffness in patients with diabetes.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05061602
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Evaluation of biomechanics and viscoelastic properties of plantar fascia
Trials testing the same drug.
- NCT05318001 — Biomechanical and Viscoelastic Properties of Plantar Fascia in Pregnant Women-Pilot Study · completed
- NCT04620993 — Biomechanical and Viscoelastic Properties of Plantar Fascia in Pregnant Women · completed
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07448805 — Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05061602 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Tülay Çevik Saldıran
- Last refreshed: 27 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05061602.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing